MeSH D012148 - restless legs syndrome
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| Boehringer Ingelheim | Pramipexole | Mirapexin |  | 1998-02-23 |  |  |
| Pramipexole | Sifrol |  | 1997-10-13 |  |  | |
| UCB | Rotigotine | Leganto |  | 2011-06-16 |  |  |
| Rotigotine | Neupro | 2023-07-22 | 2007-05-09 |  |  |
1
2
3
4
>
Clinical Trials
Historical Success Rate
Phase 1
67%12/18
Phase 2
52%17/33
Phase 3
52%13/25
Approved: 5Overall Success rate: 18%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
1
2
3
>
© 2020-2023 Collaborative Drug Discovery Inc. (CDD) | Terms of Use